Home > Drug Category > Cancer Medications > Jakafi and Equivalent > Jakafi 15 mg

Brand Jakafi 15 mg from Canada by Novartis

The brand Jakafi 15 mg comes from Canada also called Jakavi manufactured by Novartis. It is available in the quantity of 56 tablets.

Jakafi (Ruxolitinib phosphate) Information

Jakafi, which contains the active ingredient ruxolitinib, is an oral targeted therapy known as a JAK (Janus Kinase) inhibitor. It is specifically indicated for the treatment of patients with intermediate or high-risk myelofibrosis, a severe bone marrow disorder. It is also used to manage polycythemia vera in individuals who have had an inadequate response to hydroxyurea, and for treating both acute and chronic graft-versus-host disease (GvHD). By specifically targeting the cellular pathways responsible for these conditions, Jakafi helps shrink an enlarged spleen and alleviate debilitating systemic symptoms such as severe itching, night sweats, and bone pain. It is usually taken as a tablet twice per day.

The mechanism of action involves the inhibition of the JAK1 and JAK2 enzymes. These kinases are part of a signaling pathway that regulates the production of blood cells and the body's inflammatory response. Under targeted conditions, this pathway is often overactive or mutated, leading to uncontrolled cell growth and elevated levels of inflammatory cytokines. Jakafi works by "turning down" this signaling, helping stabilize blood cell counts, reduce inflammation, and decrease the physical size of the spleen.

If you have any questions about placing your order, contact us at our toll-free service at 1.877.223.9977. Our dedicated toll-free customer service representative will help provide support from Monday to Friday 5:30am to 6:00pm and weekends Saturday/Sunday 7:00am to 3:30pm (PST).

Do I need a prescription to order Jakafi 15 mg ?

Yes, a prescription is required from your physician to order Jakafi 15 mg.